Skip to content
RWAY

Runway Growth Finance Corp.

Runway Growth Finance Corp. Q4 FY2024 earnings call

March 20, 2025 · fiscal period ended 2024-12

EPS · actual vs est

$0.39 / $0.42Miss -7.1%

Revenue · actual vs est

$59.9M / $33.8MBeat +77.0%
Ask about this call

Summary

Generated 2025-03-20

Management highlights

  • Fourth quarter results: total investment income $33.8M, net investment income $14.6M. - Acquisition of investment adviser by BC Partners Credit: closed in Jan, Runway Growth Capital remains investment adviser. - Portfolio performance: focus on late and growth stage, strong credit quality. - Origination plans: Runway Growth Capital seeking to grow originations in loan size $30M to $150M, ideal allocation to BDC $20M to $45M. - Venture debt sector: deal value increased to over $53B in 2024, Runway positioned to benefit from sector tailwinds. - Rating system: loans start as Category 2, deviation from plan can move to Category 3 but most still pay loans on time. - Capital allocation: Board declared $0.36 per share dividend for Q1 2025, base dividend $0.33 per share, supplemental up to 50% of NII excess over base.
View in transcript ↓

Segment performance

For the fourth quarter, Runway delivered total investment income of $33.8 million and net investment income of $14.6 million. The weighted average portfolio risk rating decreased to 2.33 in Q4 2024 from 2.48 in Q3 2024. The dollar-weighted loan-to-value ratio decreased from 29.3% to 26.6%. The total investment portfolio, excluding U.S. Treasury Bills, had a fair value of approximately $1.08 billion, an increase from $1.07 billion in Q3 2024. Net assets were $514.9 million at Dec 31, 2024, up from $507.4 million in Q3 2024. NAV per share was $13.79, up 3% from Q3 2024. The loan portfolio is 97% floating rate. Total operating expenses were $19.2 million in Q4 2024, down from $20.8 million in Q3 2024. Net realized loss on investments was $2.9 million in Q4 2024. Two loans were on non-accrual status, representing 0.5% of the total investment portfolio. Leverage ratio and asset coverage remained at 1.08 times and 1.92 times respectively. Total available liquidity was $244.8 million, and unfunded commitments were $176.7 million. The Board declared aggregate distributions of $0.36 per share for Q1 2025.

View in transcript ↓

Guidance

  • Runway Growth Capital seeking to grow originations in loan size $30M to $150M, ideal BDC allocation $20M to $45M. - Expect focus to diversify BDC portfolio, leverage BC Partners' scale and expertise. - Anticipate venture debt sector tailwinds to continue, Runway positioned to execute. - Board aims for stable and consistent dividend with base dividend $0.33 per share and supplemental up to 50% of NII excess over base.
View in transcript ↓

Risks

  • Market conditions caused by uncertainties surrounding interest rates. - Changing economic conditions. - Other factors identified in SEC filings that could cause actual results to differ from forward-looking statements. - Potential inaccuracies in assumptions underlying forward-looking statements.
View in transcript ↓

Q&A highlights

Q: Was there expected additional originations in the next 10 days before the quarter ends?

A: Greg Greifeld said originations are typically back-ended, working with companies and could have originations closed this quarter but some might push to next quarter.

Q: What percentage of loan book is trading at interest rate floors?

A: Greg Greifeld said majority are at or above floors, newer deals at floors, older deals above floors.

Q: Thoughts on dividend change and Board of Directors changes?

A: Tom Raterman said Board wants stable dividend, adopted base dividend sustainable, no change in leverage target, new Board recognizes importance of consistent dividend.

Q: Broader understanding of origination opportunity set with BC Partners?

A: Greg Greifeld said BC Partners' platform brings more eyes, expertise to underwrite different structures, funnel to expand with larger network.

Q: Gains or losses on equity and warrant positions?

A: Tom Raterman said Gynesonics merger led to gain, mostly reflected in fair value at 12/31.

Q: Expectation of share repurchases?

A: Tom Raterman said management and Board discuss, will assess what creates better return for building portfolio and value.

Q: Venture market and capital markets activity?

A: Greg Greifeld said selected company activity continues, exits slower, expectation of uptick in new fundings and M&A volume in next quarters.

Q: Equity portfolio size and management?

A: Tom Raterman said equity portfolio is debt investor focus, driven by certain events, always looking to realize liquid investments.

Q: Spillover amount and guidance?

A: Tom Raterman said goal is to maintain at least one quarter of spillover and grow in coming quarters.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.39$0.42-7.1%$0.45
Revenue$59.9M$33.8M+77.0%$22.0M

Transcript

March 20, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.